The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

BACKGROUND: Nanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of two orally administe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Part Fibre Toxicol
Main Authors: Li, Juan, Lei, Runhong, Li, Xin, Xiong, Fengxia, Zhang, Quanyang, Zhou, Yue, Yang, Shengmei, Chang, Yanan, Chen, Kui, Gu, Weihong, Wu, Chongming, Xing, Gengmei
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773151/
https://ncbi.nlm.nih.gov/pubmed/29343276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12989-018-0241-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki